Other equities research analysts have also recently issued reports about the company. UBS Group cut their target price on Proximus from €13.90 ($14.18) to €13.30 ($13.57) and set a neutral rating for the company in a research note on Tuesday, August 9th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Proximus from €21.50 ($21.94) to €12.50 ($12.76) in a report on Friday, August 19th. Morgan Stanley started coverage on shares of Proximus in a report on Friday, September 2nd. They set an underweight rating for the company. Finally, JPMorgan Chase & Co. lowered their price target on shares of Proximus from €20.50 ($20.92) to €18.00 ($18.37) and set a neutral rating for the company in a report on Wednesday, June 29th. Four research analysts have rated the stock with a sell rating and two have issued a hold rating to the company. Based on data from MarketBeat, Proximus has a consensus rating of Reduce and a consensus price target of $13.95.
Proximus Stock Performance
OTCMKTS BGAOY opened at $2.18 on Friday. The business has a fifty day moving average price of $2.60 and a two-hundred day moving average price of $3.14. Proximus has a fifty-two week low of $2.15 and a fifty-two week high of $4.20.
Proximus Company Profile
Proximus PLC provides digital services and communication solutions in Belgium and internationally. It operates through Domestic, International Carrier Services, and TeleSign segments. The company offers fixed and mobile telephony, internet, and television services to residential customers and small businesses; telecommunication, ICT infrastructure, multi-cloud, digital finance, cybersecurity, business applications, and managed and training services to medium and large companies, and public administrations; and ICT services to residential, business, and telecom wholesale markets.
- Get a free copy of the StockNews.com research report on Proximus (BGAOY)
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- 3 Banks Worth Considering For Q4
- No One Told These 3 Stocks It’s a Down Week
- MarketBeat: Week in Review 9/12 – 9/16
- Is There a Cure for What is Ailing Teladoc Stock?
Receive News & Ratings for Proximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proximus and related companies with MarketBeat.com's FREE daily email newsletter.